OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Update on Ocular Complications of Systemic Cancer Chemotherapy
Katharina Schmid, Gabriela Kornek, Werner Scheithauer, et al.
Survey of Ophthalmology (2006) Vol. 51, Iss. 1, pp. 19-40
Closed Access | Times Cited: 139

Showing 1-25 of 139 citing articles:

Diagnostic and Therapeutic Challenges
Mohammad Ali Sadiq, Graeme K. Loh, Yasir J. Sepah, et al.
Retina (2014) Vol. 35, Iss. 6, pp. 1279-1282
Closed Access | Times Cited: 219

Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents
Neife Aparecida Guinaim dos Santos, Rafaela Scalco Ferreira, Antônio C. Santos
Food and Chemical Toxicology (2019) Vol. 136, pp. 111079-111079
Open Access | Times Cited: 158

On-demand controlled release of docetaxel from a battery-less MEMS drug delivery device
Fatemeh Nazly Pirmoradi, John K. Jackson, Helen M. Burt, et al.
Lab on a Chip (2011) Vol. 11, Iss. 16, pp. 2744-2744
Closed Access | Times Cited: 112

Ocular adverse events of molecularly targeted agents approved in solid tumours: A systematic review
Olivier Huillard, S. Bakalian, Christine Lévy, et al.
European Journal of Cancer (2013) Vol. 50, Iss. 3, pp. 638-648
Closed Access | Times Cited: 76

Early safety assessment of human oculotoxic drugs using the zebrafish visualmotor response
Sudhakar Deeti, Sean O’Farrell, Breandán N. Kennedy
Journal of Pharmacological and Toxicological Methods (2013) Vol. 69, Iss. 1, pp. 1-8
Open Access | Times Cited: 76

RETINAL TOXICITIES OF CANCER THERAPY DRUGS
Catherine Y. Liu, Jasmine H. Francis, Scott E. Brodie, et al.
Retina (2014) Vol. 34, Iss. 7, pp. 1261-1280
Open Access | Times Cited: 64

Evaluation and Management of Chemotherapy-Induced Epiphora, Punctal and Canalicular Stenosis, and Nasolacrimal Duct Obstruction
Constanza Mansur, Margaret L. Pfeiffer, Bita Esmaeli
Ophthalmic Plastic and Reconstructive Surgery (2016) Vol. 33, Iss. 1, pp. 9-12
Closed Access | Times Cited: 50

Known and novel ocular toxicities of biologics, targeted agents, and traditional chemotherapeutics
Anne L. Kunkler, Elaine M. Binkley, Dimosthenis Mantopoulos, et al.
Graefe s Archive for Clinical and Experimental Ophthalmology (2019) Vol. 257, Iss. 8, pp. 1771-1781
Closed Access | Times Cited: 43

Chemobrain: A translational challenge for neurotoxicology
Bernard Weiss
NeuroToxicology (2008) Vol. 29, Iss. 5, pp. 891-898
Open Access | Times Cited: 70

Ocular Adnexal Lymphoma of the Extraocular Muscles: Case Series From the University of Iowa and Review of the Literature
Lynnette M. Watkins, Keith D. Carter, Jeffrey A. Nerad
Ophthalmic Plastic and Reconstructive Surgery (2011) Vol. 27, Iss. 6, pp. 471-476
Closed Access | Times Cited: 51

Vision Changes After Head and Neck Cancer Treatment
Hsiao‐Lan Wang, Megan Heskett, Peng Li, et al.
Head & Neck (2025)
Open Access

Principles and Complications of Chemotherapy
Stacey Zahler, Nicola G. Ghazi, Arun D. Singh
Clinical ophthalmic oncology (2025), pp. 137-149
Closed Access

Emerging toxicities in the treatment of non-small cell lung cancer: Ocular disorders
Francesco Agustoni, Marco Platania, Milena Vitali, et al.
Cancer Treatment Reviews (2013) Vol. 40, Iss. 1, pp. 197-203
Open Access | Times Cited: 43

Retinal toxicities of systemic anticancer drugs
Supriya Arora, Thamolwan Surakiatchanukul, Tarun Arora, et al.
Survey of Ophthalmology (2021) Vol. 67, Iss. 1, pp. 97-148
Closed Access | Times Cited: 26

Medical Issues in Cancer Survivors—A Review
Kenneth D. Miller, Laura R. Triano
The Cancer Journal (2008) Vol. 14, Iss. 6, pp. 375-387
Closed Access | Times Cited: 44

Ocular Complications of Systemic Medications
Preston H. Blomquist, Biff F. Palmer
The American Journal of the Medical Sciences (2010) Vol. 342, Iss. 1, pp. 62-69
Closed Access | Times Cited: 37

Ocular toxicity from systemically administered xenobiotics
Mitan Gokulgandhi, Aswani Dutt Vadlapudi, Ashim K. Mitra
Expert Opinion on Drug Metabolism & Toxicology (2012) Vol. 8, Iss. 10, pp. 1277-1291
Open Access | Times Cited: 36

Vigabatrin: Lessons Learned From the United States Experience
Rod Foroozan
Journal of Neuro-Ophthalmology (2017) Vol. 38, Iss. 4, pp. 442-450
Open Access | Times Cited: 29

Effects of cisplatin-5-fluorouracil combination therapy on oxidative stress, DNA damage, mitochondrial apoptosis, and death receptor signalling in retinal pigment epithelium cells
Hande Güçlü, Zeynep Banu Doğanlar, Vuslat Gürlü, et al.
Cutaneous and Ocular Toxicology (2018) Vol. 37, Iss. 3, pp. 291-304
Closed Access | Times Cited: 28

Prevalence of symptomatic dry eye in breast cancer patients undergoing systemic adjuvant treatment: A cross-sectional study
Jinfei Ma, Emmanuel Eric Pazo, Zihao Zou, et al.
The Breast (2020) Vol. 53, pp. 164-171
Open Access | Times Cited: 23

Nanotechnology in the Treatment and Detection of Intraocular Cancers
Ashwin Nair, Paul Thevenot, Wenjing Hu, et al.
Journal of Biomedical Nanotechnology (2008) Vol. 4, Iss. 4, pp. 410-418
Open Access | Times Cited: 31

Effects on the visual system might contribute to some of the cognitive deficits of cancer chemotherapy-induced ‘chemo-fog’
Robert B. Raffa, Ronald J. Tallarida
Journal of Clinical Pharmacy and Therapeutics (2010) Vol. 35, Iss. 3, pp. 249-255
Open Access | Times Cited: 27

Assessment of ocular neurotoxicity in patients treated with systemic cancer chemotherapeutics
Berker Bakbak, Şansal Gedik, Bengü Ekinci Köktekir, et al.
Cutaneous and Ocular Toxicology (2013) Vol. 33, Iss. 1, pp. 7-10
Closed Access | Times Cited: 24

Posterior Segment Toxicity after Gemcitabine and Docetaxel Chemotherapy
Ali Kord Valeshabad, William F. Mieler, Vikram Setlur, et al.
Optometry and Vision Science (2015) Vol. 92, Iss. 5, pp. e110-e113
Open Access | Times Cited: 23

Corneal Edema and Opacification Preferred Practice Pattern®
Marjan Farid, Michelle K. Rhee, Esen K. Akpek, et al.
Ophthalmology (2018) Vol. 126, Iss. 1, pp. P216-P285
Closed Access | Times Cited: 22

Page 1 - Next Page

Scroll to top